Clinical Trial Update: Safe Study of Dendritic Cell (DC) Based Therapy Targeting Tumor Stem Cells in Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

The completed Phase 1/2 clinical trial evaluated a dendritic cell–based therapy targeting tumor stem cells in glioblastoma, focusing on safety outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Dendritic Cell-Based Therapy (tumor stem cell targeting)

Snippet

Sponsor: Oslo University Hospital | Conditions: Glioblastoma, Brain Tumor | Phase 1, Phase 2 | Status: COMPLETED